对瘤免疫微环境中的m7G相关特征的分析和对卵巢癌临床预后调节者的鉴定
在PubMed上查看摘要
概括
此摘要是机器生成的。这项研究揭示了m7G修饰基因如何影响卵巢癌 (OV) 的发展,确定了两个关键基因DCP2和NUDT16,用于预测OV患者的预后和免疫治疗反应.
科学领域
- 癌症学
- 分子生物学
- 遗传学
背景情况
- 卵巢癌 (OV) 是全世界妇科癌症死亡的主要原因.
- 与m7G修饰相关的基因在OV病变中的作用尚不清楚.
研究的目的
- 研究m7G修饰相关基因对卵巢癌发展的影响.
- 在OV中确定预后生物标志物和潜在的治疗点.
主要方法
- 基于24个m7G修饰相关基因的OV样本的共识聚类.
- 差异基因表达分析,丰富分析 (路径,生物过程) 和多变量考克斯回归.
- 对关键基因进行预测风险评分模型构建和网络分析.
主要成果
- 鉴定出两种不同的OV亚型, 具有不同的免疫细胞透.
- 发现DCP2和NUDT16与OV预后有显著的关联.
- 开发了一种风险评分模型,证明高风险评分与较短的存活时间和影响免疫治疗反应相关.
结论
- 与m7G修饰相关的基因,特别是DCP2和NUDT16,在卵巢癌的发展和进展中起着至关重要的作用.
- 确定的风险评分模型可以作为独立的预后因素,并预测OV的免疫治疗反应.
- 这项研究为卵巢癌背后的分子机制提供了新的见解, 并提出了潜在的治疗策略.
相关概念视频
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

